Introduction
caffeic acid plus dihydrocaffeic acid (→KHYKOP), caffeic acid plus gallic acid (→KGALOP). If not stated otherwise, all polyhydroxycarboxylates were used as sodium salts. Dextran sulfate (MW 5000) was obtained from Pfeifer & Langen (Dormagen, Germany).
Preparation, measurement of molecular weight and functional group analysis
The methods for preparation, MW measurements and func-tional group determinations were described previously (Helbig et al., 1997) .
Preparation of phenolic polymers. Starting compounds were oxidized with sodium m-periodate or periodic acid at 55°C and pH 8-9 for 1 h and left at room temperature overnight. Then, the humic acid-like polymers formed were isolated by precipitation with an organic solvent, preferably ethanol.
A Meerbach et al. Detection of carboxylic groups and phenolic hydroxylic groups. Carboxylic groups and phenolic hydroxylic groups were detected with barium hydroxide and calcium acetate, respectively, according to Schnitzer and Khan (1972) .
Viruses
The virus strains used were: herpes simplex virus type 1 (HSV-1, strain KOS), type 2 (HSV-2, strain G), thymidine kinase deficient (TK -) HSV-1 (strain B2006), human cytomegalovirus (HCMV, strains Davis and AD169) as well as human immunodeficiency virus type 1 (HIV-1, strain III B ) and type 2 (HIV-2, strain ROD).
Cells
Human embryonic lung (HEL) fibroblasts were grown in MEM supplemented with 10% fetal calf serum, 2 mM Lglutamine and 0.02% sodium bicarbonate. The T-lymphocyte cell line CEM was cultivated in RPMI 1640 medium supplemented with 10% fetal calf serum, 0.075% sodium bicarbonate and 2 mM L-glutamine.
Detection of antiviral activity
Herpes simplex virus, human cytomegalovirus. HIV. CEM cells (4×10 5 ) were infected with HIV-1 or HIV-2 at 100 CCID 50 /ml. Then, 100 µl aliquots of the infected cell suspension were added to the wells of a 96-well microtitre plate containing a 100 µl solution with varying concentrations of the test substances. After a 4-day incubation period at 37°C, the percentage of HIV-induced syncytium (CEM giant cell formation) was examined microscopically and EC 50 values were calculated. The antiviral activity was expressed as the concentration required to protect 50% of the HIV-infected cells from giant cell formation (EC 50 ).
Effect on cell growth
HEL cells were seeded at 5000 cells/well in 96-well microtitre trays in MEM containing 20% fetal calf serum, and allowed to stick to the bottom of the plates for 24 h. Different concentrations of the test substances were added and the cells were allowed to proliferate for 3 days. The supernatant was removed and the cells were detached by trypsinization, counted with a Coulter Counter and the 50% cytotoxic concentrations (CC 50 ) were calculated. CEM cells were seeded at a density of 40 000/well in RPMI 1640 medium containing 10% fetal calf serum and incubated together with the test compounds for 4 days. The cell number was determined with a Coulter Counter. The concentrations required to inhibit the proliferation of CEM cells by 50% (CC 50 ) were calculated.
Detection of human cytomegalovirus-induced immediate early antigen expression
The assay was carried out in 4-well tissue culture chamber slides containing confluent HEL cells treated with different concentrations of the test compounds. The cells were infected with HCMV (Davis) at a multiplicity of infection of 0.2. HCMV immediate early antigen (IEA) expression was evaluated 24 h after infection by means of the fluorescence anti- 
Analysis of virus-cell binding
Confluent HEL cells grown in 96-well microtitre plates were treated with 50 µl of the different concentrations of the test compounds for 5 min at room temperature. After addition of 5 µl of radiolabelled virus suspension (HCMV, Davis) (10 8 PFU/ml, 5×10 6 cpm/ml), the cell cultures were further incubated at 37°C for 60 min. Then the inoculum was removed. Cells were washed four times with phosphate-buffered saline. The cell suspension was spotted on GF/C filters (Whatman), and the radioactivity was measured using a toluene-based scintillant. The concentrations required to inhibit binding of radiolabelled virions to the cells by 50% were calculated.
Results

Activity against herpesviruses (herpes simplex virus and human cytomegalovirus)
Of the 17 polyanionic compounds studied KOP (sodium, ammonium, and potassium salt), KGALOP, KHYKOP, and GALMEOP proved to be particular selective inhibitors of HSV and HCMV infection. The most effective compounds yielded EC 50 values of 4.1-8.3 µg/ml (HSV-1), 6.0-8.7 µg/ml (HSV-1-TK -), 1.7-5.9 µg/ml (HSV-2), 2.8-8.4 µg/ml (HCMV, AD169) and 3.5-8.8 µg/ml (HCMV, Davis) and selectivity indices of 8-20, 7-19, 18-43, 9-26 and 8-21, respectively (Table 2 ). The anti-HSV and anti-HCMV effects of 3,4-DHBEEOP, 6,7-DH-4-MECUMOP, PYR-1-MEOP, GALPEOP, and ADROP were less pronounced, and NORADROP, ISOPROP, ADROLOP and 2,3-DHPYRIDOP had little or no antiherpesvirus activity. The phenolic polymers inhibited the binding of radiolabelled HCMV particles to the cells as well as the expression of IEA in HCMV infected cells. The EC 50 values (Table 3) calculated for inhibition of IEA expression and binding of radiolabelled viruses to the cells were in the same range, although somewhat lower than the EC 50 values of virusinduced cytopathogenicity. A compound that proved inactive in the HCMV-induced cytopathicity assay (2,3-DHPYRI-DOP), also proved ineffective in the binding assay, as well as the IEA expression assay.
Activity against HIV
As presented in Table 4 , all phenolic polymers studied inhibited HIV-induced syncytium formation in CEM cells. Except for NORADROP, ISOPROP, ADROLOP and 2,3-DHPYRIDOP, all other compounds inhibited HIV-1 and HIV-2 replication within a narrow activity range of EC 50 values between 1.2 and 5.5 µg/ml, resulting in a selectivity index ranging from 16 to >83. There were no major differences for the inhibitory activities of the test compounds against HIV-1 and HIV-2. The reference compound dextran sulfate was 3-to 10-fold more inhibitory than the most active phenolic polymers. Figure 2 summarizes the antiviral activity of a selection of 12 phenolic polymers against herpesviruses and HIV. There was a good correlation for the antiviral activities of the test compounds against HSV and HCMV and HSV and HIV. The correlation coefficients were 0.97 and 0.89, respectively (Figure 3 ).
Discussion
The present study was aimed at evaluating the antiviral activity of a new series of polyhydroxycarboxylates against herpesviruses (HSV, HCMV) and HIV. Several of the phenolic polymers were found to be effective inhibitors of HSV-1, HSV-1-TK -, HSV-2 and HCMV at concentrations that were not toxic to the host cells (HEL cells). EC 50 values for inhibition of (1) HCMV-specific IEA expression, (2) binding of radiolabelled HCMV particles to the cells and (3) HCMV-induced cytopathicity were in the same range although somewhat higher for the cytopathic effects data. Although the virus-induced cytopathicity was measured after a 7-day incubation period, IEA expression was read after 24 h, and the virus binding experiments were stopped after 1 h. The somewhat higher EC 50 values for cytopathicity might be due to the longer incubation period.
Of the compounds evaluated, KOP (sodium-, ammonium-and potassium salt), KGALOP, KHYKOP and GALMEOP emerged as the most potent anti-HSV and anti-HCMV agents (EC 50 <10µg/ml). In an additional experiment the antiviral activity of the compounds with the HSV-1 (KOS)/Vero cell system was proved (data not shown). The results are comparable to those with the HEL cells. Because of less cytotoxicity of the compounds to Vero cells the selectivity index became higher, resulting in a better cytotoxicity window. Vero cells are green monkey kidney cells but impress morphologically like epithelial cells. Neyts et al. (1992b) described a good antiviral activity of the first panel of polyhydroxycarboxylates with the skinmuscle cell line E 6 SM and the HSV-1 (KOS), TK -HSV-1 (B2006) and HSV-2 (G) virus strains. Findings with Vero cells and E 6 SM cells provide further evidence that polyhydroxycarboxylates are potential candidates for a possible topical treatment of HSV infections.
The antiherpetic activity of the polyhydroxycarboxylates can be ascribed to the inhibition of virus adsorption to the target cells. The polyanionic substances may block the attachment of viruses to the cells by interacting with positively charged domains of the viral envelope glycoproteins that are necessary for attachment to the cellular receptor heparan sulfate (Neyts et al., 1992a (Neyts et al., ,b, 1995 .
All polymers studied also inhibited HIV-induced syncytium formation in CEM cells. With exception of NORADROP, ISOPROP, ADROLOP and 2,3-DHPYRIDOP, which showed moderate antiretrovirus activity, all other polymers markedly inhibited the replication of HIV-1 and HIV-2 in cell culture. Previously, Schols et al. (1991) investigated the effect of a first panel of 13 polyhydroxycarboxylates, synthesized in the Institute for Antiviral Chemotherapy, on HIV replication, virus adsorption, OKT4/leu3a mAb binding to the CD4 receptor and anti-gp120 mAb binding to gp120. Among the compounds caffeic acid oxidation product (KOP), gallic acid oxidation product (GALOP), gentisinic acid oxidation product (GENOP), hydrocaffeic acid oxidation product (HYKOP), pyrogallol oxidation product (PYROP), chlorogenic acid oxidation product (CHOP), protocatechuic acid oxidation The antiviral EC 50 values of herpes simplex and HIV are the mean for herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), and HIV-1 and HIV-2, respectively. HCMV, human cytomegalovirus.
(a) (b) product (POP) and polymers derived from dihydroxyphenylacetic acid (DHPOP) showed a 50% anti-HIV-1 and -2 inhibitory concentration of 5-17 µg/ml. The inhibitory effects of these test compounds on virus adsorption were measured by an indirect immunofluorescencelaser flow cytofluorographic method. The polyhydroxycarboxylates suppress HIV-1 binding to MT-4 cells. At 20 µg/ml 11 of the 13 compounds achieved a very strong inhibition effect on virus binding. Using gp120 and CD4 immunofluorescence assays the authors found that the compounds inhibit the first step in the virus replicative cycle (that is, virus adsorption to the cells) through interference with the viral glycoprotein gp120-CD4 cell receptor interaction. The mechanism of action may be attributed to inhibition of the interaction between the viral glycoprotein gp120 and the cellular CD4 receptor. In general, polyanionic compounds exhibit their anti-HIV activity by binding to the V3 domain of gp120 (Baba et al., 1988b; Nakashima et al., 1989; Schols et al., 1991 , 1992 , Witvrouw et al., 1994 . Although the polyanions inhibit the binding of herpesviruses and HIV, and thus indirectly prevent the subsequent fusion process as well, their effects on the replication of influenza virus can be ascribed primarily to inhibition of virus-cell fusion (Lüscher-Mattli & Glück, 1990; Ikeda et al., 1994) . The most antivirally effective phenolic polymers were the different salt forms of KOP (sodium-, ammonium-, potassium salt) as well as the copolymers containing KOP (KHYKOP, KGALOP). In previous studies Neyts et al. (1992b) also reported inhibition of HSV and HCMV replication by the more simple polymers HYKOP and GALOP. They studied the inhibition of radiolabelled HCMV virions to the cells and demonstrated that KOP, GALOP and HYKOP are able to displace CMV virions that were bound to heparin immobilized on a Sepharose column. They concluded that polyhydroxycarboxylates compete with heparin for binding to those sites of the virion envelope that are necessary for attachment of the virus particles to the cell surface.
The antiviral potency of the phenolic polymers appears to depend on the presence of functional acidic groups. The presence of carboxylic groups are a prerequisite for the antiviral activity of the phenolic polymers (Helbig et al., 1997) . Caffeic acid, the monomer of KOP, is characterized by the presence of a C=C double bond in the side chain, which may be responsible for the enhanced antiviral activity of the KOP-containing polymers. Helbig et al. (1997) observed no correlation between the number of phenolic OH groups and the anti-HSV activity, suggesting that the number of these groups does not play a role, or only plays a secondary role in the antiviral efficacy of the compounds. The presence of a nitrogen in the starting phenolic compound, on the other hand, decreased the antiviral activity of the oxidation products, as observed with NORADROP, ADROP, ADROLOP, ISOPROP and 2,3-DHPYRIDOP. Overall a good correlation was observed between the antiherpes virus and anti-HIV activity of the compounds studied.
Lüscher-Mattli (2000) summarized in a review the advantages of anionic polymers as antiviral agents: broad- spectrum antiviral activity against various enveloped RNA and DNA viruses, the ability to inhibit syncytium formation between HIV-infected and normal CD4 T lymphocytes and low potential for virus drug resistance. In contrast to the advantages shown for these compounds in cell culture assays, the in vivo data demonstrate low bioavailability and short plasma half-life. Side-effects like anticoagulant activity and thrombocytopenia represent additional disadvantages. Lüscher-Mattli postulated that the development of drug delivery systems (for example liposomes) might be useful in improving the pharmacokinetics of polyanions in order to become therapeutically relevant antiviral drugs.
Although the systemic use of the polyanionic compounds for the treatment of viral infections may be questionable, non-toxic substances that prevent the attachment of viruses such as HSV-2 and HIV to their target cells may be useful in vaginal gel formulations. Women may use such formulations to prevent sexual transmission of HSV and HIV and possibly other infectious pathogens (for example, Neisseria, Chlamydia) as well. Greenhead et al. (2000) first demonstrated that virucidal agents designed for topical vaginal use block HIV infection of genital tissue by means of an explant culture model. We have shown earlier that the polyanionic compound PAVAS protects mice against intravaginal challenge with HSV-2 . Recently, we demonstrated that the non-toxic hydrogel formulation, containing the 1-monoglyceride of capric acid (monocaprin) as the active ingredient, efficiently prevents intravaginal and intracutaneous HSV-2 infections in mice (Neyts et al., 2000) . Bourne et al. (1999) reported on the topical microbicide PRO 2000, a naphthalene sulfonate polymer, which protects mice against genital herpes infection. The results of a study in macaques suggested that the HIV entry inhibitors dextrin-2-sulfate and PRO 2000 protects against Simian HIV vaginal challenge (Weber et al., 2001) . In clinical Phase I and Phase II studies dextrin sulfate gel and PRO 2000 gel formulations were found to be well tolerated, with promising local and systemic safety (Stafford et al., 1997 , Van Damme et al., 2000 . Thus, polyanionic compounds can be considered as candidates for use in a topical chemoprophylactic formulation.
